SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy
Kathryn J. Swoboda, Charles B. Scott, Thomas O. Crawford et al. · 2010
Read SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy by Kathryn J. Swoboda, Charles B. Scott, Thomas O. Crawford et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012140.txt.
Description
Kathryn Swoboda, Charles Scott, Thomas Crawford, and colleagues reported a clinical trial in spinal muscular atrophy for PLOS ONE in 2010. This inherited disease weakens muscles by killing the nerve cells that drive them. Valproic acid, a drug long used for seizures, had shown promise for this disease in lab and animal work, and the trial added a supplement, L-carnitine, beside it.
Children and young patients joined in two groups: those who could sit but not walk, and those who could still walk. Half received the real treatment and half a dummy one, with neither side knowing which. Trials reported this carefully, part by part, give families and doctors trustworthy ground for judging a hoped-for therapy.
Catalog record
| CREATOR | Kathryn J. Swoboda, Charles B. Scott, Thomas O. Crawford et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012140